tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX

Travere Therapeutics (TVTX) Stock Investors

325 Followers
Based on 746,050 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold TVTX
On average, investors allocate 0.00% of their portfolios to TVTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,050 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding TVTX

3.1%
Last 7
Days
7.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding TVTX, out of 746,050 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

TVTX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,161 investors who made their portfolios public
The table shows changes in TVTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

TVTX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.54%
-1.63%
-5.07%
190.44M
Healthcare
Merck & Company
3.91%
+0.47%
+3.85%
323.59B
Healthcare
Applied Materials
4.69%
+0.17%
+6.24%
201.53B
Technology
Bristol-Myers Squibb
3.16%
-1.17%
+1.66%
82.02B
Healthcare
DraftKings
5.81%
-0.98%
-1.43%
33.23B
Consumer Cyclical
ChargePoint Holdings
4.22%
-1.02%
-2.55%
935.67M
Consumer Cyclical
Marathon Digital Holdings
5.57%
-0.98%
-0.18%
5.67B
Financial
Block
4.21%
-0.90%
+0.36%
42.42B
Technology
Baidu
5.26%
+3.04%
+13.53%
36.99B
Communication Services
Plug Power
5.06%
-0.98%
-2.47%
2.28B
Industrials
Based on the activity of 746,050 active portfolios
Open your Smart Portfolio

TVTX Investor Analysis

TVTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.9%
of TVTX holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
TVTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
45.7%
of TVTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
TVTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
43.5%
of TVTX holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of TVTX stock investors
See who invests in TVTX according to age group and performance.

FAQ

How many retail Investors hold TVTX?
<0.1% of TipRanks' retail investors hold TVTX in their portfolios.
    What is TVTX Investor Sentiment?
    TVTX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of TVTX in the last 7 days?
      ▼ 3.1% of TipRanks' retail investors changed their holding of TVTX in the last 7 days.
        What percentage of retail investors changed their holding of TVTX in the last 30 days?
        ▼ 7.9% of TipRanks' retail investors changed their holding of TVTX in the last 30 days.
          What is the average age of retail investors who hold TVTX?
          The average age of TVTX Holders is between 35–55.
            What other stocks have TVTX investors also bought?
            TVTX Investors also bought CHRS, MRK, AMAT, BMY, DKNG, CHPT, MARA, SQ, BIDU, PLUG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BSXBoston Scientific
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              HAEHaemonetics
              INSMInsmed
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis